CELLCENTRIC
CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga. The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
CELLCENTRIC
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2003-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cellcentric.com
Total Employee:
1+
Status:
Active
Contact:
44 1799 531 130
Total Funding:
75.64 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Nginx Euro
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
BrightEdge Fund
BrightEdge Fund investment in Venture Round - CellCentric
Morningside Venture Partners
Morningside Venture Partners investment in Venture Round - CellCentric
Morningside Venture Investments
Morningside Venture Investments investment in Venture Round - CellCentric
Morningside Venture Partners
Morningside Venture Partners investment in Venture Round - CellCentric
Nesta Ventures
Nesta Ventures investment in Venture Round - CellCentric
Innovate UK
Innovate UK investment in Grant - CellCentric
Providence Investment Company Limited
Providence Investment Company Limited investment in Venture Round - CellCentric
Morningside Venture Partners
Morningside Venture Partners investment in Venture Round - CellCentric
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Venture Round - CellCentric
5Y Capital
5Y Capital investment in Venture Round - CellCentric
Official Site Inspections
http://www.cellcentric.com Semrush global rank: 5.64 M Semrush visits lastest month: 1.5 K
- Host name: 172.67.132.225
- IP address: 172.67.132.225
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
